https://doctransparency.com/doctor/tx/dallas/parvez-mantry-1770528697
Medicare Enrolled

Dr. Parvez Mantry, MD

Hepatology Physician · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
1411 N BECKLEY AVE, Dallas, TX 75203
2149474400
In practice since 2006 (19 years)
NPI: 1770528697 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mantry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mantry? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mantry

Dr. Parvez Mantry is a hepatology physician in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Mantry performed 536 Medicare services across 374 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mantry received a total of $795,245 from 52 pharmaceutical and/or device companies across 949 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hepatology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mantry is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 36% volume in TX$ $795,245 industry payments

Medicare Practice Summary

Medicare Utilization ↗
536
Medicare services
Top 36% in TX for hepatology physician
374
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~28 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)353$86$330
New patient office visit (45-59 min)71$113$426
Hospital follow-up visit, moderate complexity51$62$180
Office visit, established patient (20-29 min)21$68$233
Upper GI endoscopy with biopsy16$86$706
Measurement of liver stiffness12$24$330
Office visit, established patient, complex (40-54 min)12$135$460
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$795,245
Total received (2018-2024)
Avg $113,606/year across 7 years
Top 4% in TX for hepatology physician
52
Companies
949
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$584,537 (73.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$206,244 (25.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,464 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$205,045
2023
$91,720
2022
$105,761
2021
$73,394
2020
$51,009
2019
$122,610
2018
$145,706

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$125,265
Gilead Sciences, Inc.
$120,480
AbbVie, Inc.
$60,130
Intercept Pharmaceuticals, Inc.
$59,562
Eisai Inc.
$58,839
Madrigal Pharmaceuticals
$49,925
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$47,454
EISAI INC.
$33,255
Biocompatibles, Inc.
$32,234
INTERCEPT PHARMACEUTICALS, INC.
$31,341
Sirtex Medical Inc
$25,144
ABBVIE INC.
$24,672
AbbVie Inc.
$23,912
Merck Sharp & Dohme Corporation
$21,585
Ipsen Biopharmaceuticals, Inc
$14,225
Shionogi Inc
$13,792
W. L. Gore & Associates, Inc.
$9,486
E.R. Squibb & Sons, L.L.C.
$7,957
Exelixis Inc.
$6,756
Janssen Biotech, Inc.
$4,241
Mallinckrodt Enterprises LLC
$4,181
Dova Pharmaceuticals
$4,029
Boston Scientific Corporation
$3,316
ORPHALAN INC
$3,149
Mallinckrodt Hospital Products Inc.
$2,927
Amgen Inc.
$2,428
Theratechnologies Inc.
$2,000
Genentech USA, Inc.
$1,530
Perspectum Diagnostics Ltd
$194
Eurofins Viracor, Inc.
$183
Mirum Pharmaceuticals, Inc.
$146
Exact Sciences Corporation
$126
Nuwellis, Inc.
$114
Sobi, Inc
$102
BOSTON SCIENTIFIC CORPORATION
$73
Siemens Medical Solutions USA, Inc.
$69
Apollo Endosurgery US Inc
$62
Dynavax Technologies Corporation
$42
Takeda Pharmaceuticals U.S.A., Inc.
$39
Laborie Medical Technologies Corp.
$38
CONMED Corporation
$31
Alexion Pharmaceuticals, Inc.
$29
VBI Vaccines (Delaware) Inc.
$27
GlaxoSmithKline, LLC.
$22
Medtronic, Inc.
$20
ALBIREO PHARMA, INC.
$20
VIVUS LLC
$19
TETRAPHASE PHARMACEUTICALS, INC.
$18
SANOFI-AVENTIS U.S. LLC
$16
Travere Therapeutics, Inc.
$14
Ethicon US, LLC
$13
Bayer HealthCare Pharmaceuticals Inc.
$13
Top 3 companies account for 38.5% of total payments
Associated products mentioned in payments ›
AVYCAZ · Aquadex Smartflow Console · Bylvay · CABOMETYX · CONMED BILIARY · CREON · CUVRIOR · Cabometyx · Cholbam · DIFICID · DOPTELET · Doptelet · EXALT · Epclusa · GATTEX · GI GENIUS · GORE VIATORR TIPS Endoprosthesis · Heplisav-B · IQIRVO · ISENTRESS · Kanuma · LIVTENCITY · Lenvima · Livdelzi · LiverMultiScan · MAVYRET · Mavyret · Molecular Reagents/Test Kit/Clinical Utilization · Mulpleta · Neuwave · Nexavar · None · OCALIVA · OPDIVO · ORBERA Intragastric Balloon System · Ozempic · PANCREAZE · PreHevbrio · RESMETIROM · REZDIFFRA · RenovaRP · SIMPONI ARIA · SIR-Spheres Microspheres · SPYGLASS · SpyGlass · THERASPHERE - BIO · THYMOGLOBULIN · TheraSphere · Trapezoid RX · UPLIZNA · VARITHENA · VIATORR Endoprosthesis · VIATORR TIPS Endoprosthesis w/ Controlled Expansion · VIEKIRA PAK · Veklury · Vemlidy · XIFAXAN · Xerava · ZEPATIER
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (74%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hepatology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for hepatology physician in TX.

Equivalent to $148,367 per 100 Medicare services performed
Looking for a hepatology physician in Dallas?
Compare hepatology physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse hepatology physicians nearby

Geographic Context

Hepatology Physicians within 10 mi
8
Per 100K population
0.3
County median income
$74,149
Nearest hospital
METHODIST DALLAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mantry is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 4%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mantry experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mantry performed 353 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mantry receive payments from pharmaceutical companies?
Yes. Dr. Mantry received a total of $795,245 from 52 companies across 949 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mantry's costs compare to other hepatology physicians in Dallas?
Dr. Mantry's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mantry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →